On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...